Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Avantel Ltd
| Audited Standalone Financial Results for Q4 and Year Ended March 31, 2026
Summary : Avantel Limited reported audited financial results with an unmodified opinion, recommended a dividend, and approved increased borrowing limits for growth, alongside new independent director appointments.
Quarterly Report Analysis & Insights
Financial Disclosures
- Standalone Cost of materials consumed: 7678.49 Lakhs (FY26)
- Standalone Employee benefits expense: 4794.67 Lakhs (FY26)
- Consolidated Cost of materials consumed: 7873.32 Lakhs (FY26)
- Consolidated Employee benefits expense: 5074.54 Lakhs (FY26)
- No provision for loss allowance made on receivables
- Standalone Revenue from operations: 22135.23 Lakhs (FY26)
- Consolidated Revenue from operations: 22287.24 Lakhs (FY26)
- Segment-wise: Communications and signal processing products: 22372.15 Lakhs, Health Care: 162.32 Lakhs (FY26)
- Standalone Net cash inflow from operating activities: 2,032.75 Lakhs (FY26)
- Consolidated Net cash inflow from operating activities: 1,004.81 Lakhs (FY26)
- Standalone Net cash outflow from investing activities: (10,308.11) Lakhs (FY26)
- Consolidated Net cash outflow from investing activities: (9,259.94) Lakhs (FY26)
- Standalone Total Assets: 42,701.54 Lakhs (March 31, 2026)
- Consolidated Total Assets: 40,984.32 Lakhs (March 31, 2026)
- Standalone Other Equity: 30,336.17 Lakhs (March 31, 2026)
- Consolidated Other Equity: 28,509.02 Lakhs (March 31, 2026)
- Company operates in a single segment (standalone)
- Imeds Global Private Limited is a wholly owned subsidiary
- Consolidated results include subsidiary with total assets Rs. 2605.98 Lakhs
Corporate Overview
- Reliance on Government of India as principal customer
- Manufacturing of Wireless Front End, Satellite communication, Embedded Systems, Signal Processing, Network Management and Software development and rendering related customer support Services
- Manufacturing of Disposable Skin Staplers, Removers and Oxygen Concentrators
- Factual, compliant, and focused on growth and governance
- Principal customer is an organization controlled by Government of India
- Communications and signal processing products
- Health Care
- Approved enhancement of borrowing limits from Rs.200 crore to Rs.350 crore
Risk Factors
- Heavy reliance on Government of India customer.
- Periodic reassessment of loss allowance for receivables.
- Figures regrouped/reclassified from previous year/period.
- Going concern assumption requires continuous evaluation.
Key Drivers
- Increased borrowing limits for expansion.
- Recommended final dividend of Re.0.20 per share.
- Appointment of two new independent directors.
- Unmodified audit opinion on financial results.
Auditor’s Report
- Unmodified opinion
Board Commentary
- Appointment of two new Additional Non-Executive Independent Directors for five years
- Reconstitution of Audit, Nomination & Remuneration, Stakeholders Relationship, and CSR Committees
- Recommended final dividend of Re.0.20 per equity share (10%) for FY26
- Dividend, if approved, payable to shareholders by June 12, 2026
- New directors not debarred by SEBI or any other authority
- Approved enhancement of borrowing limits to Rs.350 crore
- Approved creation of charge/mortgage for borrowing limits
Corporate Governance
- Two Additional Non-Executive Independent Directors appointed
- Audit, Nomination & Remuneration, Stakeholders Relationship, CSR Committees reconstituted
Management Discussion & Analysis
Future Strategy
- Corporate strategy aims at creating multiple drivers of growth anchored on core competence